BB Biotech's total assets for Q2 2025 were CHF1.84B, a decrease of -5.33% from the previous quarter. GB:0JYO total liabilities were CHF2.43M for the fiscal quarter, a -44.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.